Relapsed or Plateau-Phase Multiple Myeloma — Open-Label, Phase 2, Proof of Concept Study in Multiple Myeloma - Denosumab
Citation(s)
An Open-Label, Multi-Center Phase 2 Trial of Denosumab in the Treatment of Relapsed or Plateau-Phase Multiple Myeloma